Glucosamine attenuates increases of intraabdominal fat, serum leptin levels, and insulin resistance induced by a high-fat diet in rats

Nutrition Research

Volumn 30, Issue 11, 2010, Pages 791-800

  Barrientos, Cornelio ^a   Racotta, Radu ^a   Quevedo, Lucía ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

Body weight; Glucosamine; Glucose tolerance; High fat diet; Intraabdominal fat; Rats

Indexed keywords

DRINKING WATER; FATTY ACID; GLUCOSAMINE; GLUCOSE; GLYCOGEN; INSULIN; LEPTIN; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALORIC INTAKE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; EPIDIDYMIS FAT; EXPERIMENTAL MODEL; FATTY ACID BLOOD LEVEL; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; GLUCOSE TOLERANCE TEST; GLYCOGEN LIVER LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAABDOMINAL FAT; LIPID DIET; LIPID STORAGE; LONG TERM CARE; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; DIET; DIETARY FATS; FATTY ACIDS, NONESTERIFIED; GLUCOSAMINE; GLUCOSE TOLERANCE TEST; INSULIN; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LEPTIN; MALE; OBESITY; RATS; RATS, WISTAR; WEIGHT LOSS;

RATTUS;

EID: 78649817410     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nutres.2010.10.008     Document Type: Article

References (60)

1. Randle P.J., Garland P.B., Hale C.N., Newsholme E.A. The glucose-fatty acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 13:780-789.
2. Rebrin K., Steil G.M., Getty L., Bergman R.N. Free fatty acid as a link in the regulation of hepatic glucose output by peripheral insulin. Diabetes 1995, 44:1038-1045.
3. Kim J.K., Wi J.K., Youn J.H. Metabolic impairment precedes insulin resistance in skeletal muscle during high-fat feeding in rats. Diabetes 1996, 45:651-658.
4. Jucker B.M., Rennings A.J., Cline G.W., Shulman G.L. 13C and 31P NMR studies on the effects of increased plasma free fatty acids on intramuscular glucose metabolism in the awake rat. J Biol Chem 1997, 272:10464-10473.
5. Krebs M., Krssak M., Novotny P., Weghuber D., Gruber S., Mlynarik V., et al. Free fatty acids inhibit the glucose-stimulated increase of intramuscular glucose-6phosphate concentration in humans. J Clin Endocrinol Metab 2001, 86:2153-2160.
6. Petersen K.F., Shulman G.I. Cellular mechanism of insulin resistance in skeletal muscle. J R Soc Med 2002, 95(Suppl 42):8-13.
7. Hissin P.J., Karnieli E., Simpson I.A., Salans J.B., Cushman S.W.A. Possible mechanism of insulin resistance in the rat adipose cell with high-fat/low-carbohydrate feeding. Depletion of intracellular glucose transport systems. Diabetes 1982, 31:589-592.
8. Marshall S., Bacote V., Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 1991, 266:4706-4712.
9. Hawkins M., Angelov I., Liu R., Barzilai N., Rossetti L. The tissue concentration of UDP-N-acetyl-glucosamine modulates the stimulatory effect of insulin on skeletal muscle glucose uptake. J Biol Chem 1996, 272:4889-4895.
10. Cooksey R.C., McClain D.A. Transgenic mice overexpressing the rate-limiting enzyme for hexosamine synthesis in skeletal muscle or adipose tissue exhibit total body insulin resistance. Ann N Y Acad Sci 2002, 967:102-111.
11. McClain D.A. Hexosamines as mediators of nutrient sensing and regulation in diabetes. J Diabetes Complications 2002, 16:72-80.
12. Buse M.G. Hexosamines, insulin resistance and the complications of diabetes. Am J Physiol Endocrinol Metab 2006, 290:E1-E8.
13. Rumberger J.M., Wu T., Hering M.A., Marshall S. Role of hexosamine biosynthesis in glucose-mediated up-regulation of lipogenic enzymes mRNA levels. Effects of glucose, glutamine, and glucosamine on glycerophosphate dehydrogenase, fatty acid synthase, and acetyl-CoA carboxylase mRNA levels. J Biol Chem 2003, 278:28547-28552.
14. Marshall P.D., Poddar S., Tweed E.M., Brandes L. Clinical inquiries: do glucosamine and chondroitin worsen blood sugar control in diabetes?. J Fam Pract 2006, 55:1091-1093.
15. Patti M.E. Nutrient modulation of cellular insulin action. Ann N Y Acad Sci 1999, 892:187-203.
16. Hawkins M., Barzilai N., Liu R., Hu M., Chen W., Rossetti L. Role of glucosamine pathway in fat-induced insulin resistance. J Clin Invest 1997, 99:2173-2182.
17. Choi C.S., Lee F.N., Youn J.H. Free fatty acids induce peripheral insulin resistance without increasing muscle hexosamine pathway product levels in rats. Diabetes 2001, 50:418-424.
18. Weigert C., Klopfer K., Hausch C., Brodbeck K., Stumvoll M., Häring H.U., et al. Palmitate-induced activation of the hexosamine pathway in human myotubes. Diabetes 2003, 52:650-656.
19. Echard B.W., Talpur N.A., Funk K.A., Bagchi D., Preuss H.G. Effects of oral glucosamine and chondroitin sulfate alone or in combination on the metabolism of SHR and SD rats. Mol Cell Biochem 2001, 225:85-91.
20. Lee K.Y., Shibutani M., Takagi H., Arimura T., Takigami S., Uneyama C., et al. Subchronic toxicity study of dietary N-acetylglucosamine in F344 rats. Food Chem Toxicol 2004, 42:687-695.
21. Anderson J.W., Nicolosi R.J., Borzelleca J.F. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, satiety consideration and efficacy. Food Chem Toxicol 2005, 43:187-201.
22. Shen L., Tso P., Woods S.C., Sakai R.R., Dvidson W.S., Liu M. Hypothalamic apolipoprotein A-IV is regulated by leptin. Endocrinology 2007, 148:2681-2689.
23. Gelardi N.L., Chung-Ja M.C., William O.H. Evaluation of insulin sensitivity in obese offspring of diabetic rats by hyperinsulinemic-euglycemic clamp technique. Pediatr Res 1991, 30:40-44.
24. Cacho J., Sevillano J., de Castro J., Herrera E., Ramos M.P. Validation of simple indexes to assess insulin sensitivity during pregnancy in Wistar and Sprague-Dawley rats. Am J Physiol Endocrinol Metab 2008, 295:E1269-E1276.
25. Masuzaki H., Paterson J., Shinyama H., Morton N.M., Mullins J.J., Seckl J.R., et al. A transgenic model of visceral obesity and the metabolic syndrome. Science 2001, 294:2166-2170.
26. Clark J.M. Experimental biochemistry 1966, WH Freeman & Co., San Francisco.
27. Ostrowska J., Luczaj W., Kasacka I., Rozanski A., Skrzydlewska E. Green tea protects against ethanol-induced lipid peroxidation in rat organs. Alcohol 2004, 32:25-32.
28. Daniel W.W. Prueba de hipótesis. Bioestadística: Base para el análisis de las ciencias de la salud 2002, 204-294. Limusa-Wiley, Mexico City.
29. Obici S., Wang J., Chowdury R., Feng Z., Siddhanta U., Morgan K., et al. Identification of a biochemical link between energy intake and energy expenditure. J Clin Invest 2002, 109:1599-1605.
30. Cadefau J., Bollen M., Stalmans W. Glucose-induced glycogenesis in the liver involves the glucose-6-phosphate-dependent dephosphorylation of glycogen synthase. Biochem J 1997, 322:745-750.
31. Barzilai N., Hawkins M., Angelov I., Hu M., Rossetti L. Glucosamine-induced inhibition of liver glucokinase impairs the ability of hyperglycemia to suppress endogenous glucose production. Diabetes 1996, 45:1329-1335.
32. Virkamäki A., Daniels M.C., Hämäläinen S., Utriainen T., McClain D., Yki- Järvinen H. Activation of the hexosamine pathway by glucosamine in vivo induces insulin resistance in multiple insulin sensitive tissues. Endocrinology 1997, 138:2501-2507.
33. Marshall S., Nadeau O., Yamasaki K. Glucosamine-induced activation of glycogen biosynthesis in isolated adipocytes. Evidence for a rapid allosteric control mechanism within the hexosamine biosynthesis pathway. J Biol Chem 2005, 280:11018-11024.
34. McGarry J.D., Dobbins R.L. Fatty acids, lipotoxicity and insulin secretion. Diabetologia 1999, 42:128-138.
35. Ogus S., Ke Y., Qui J., Wang B., Chehab F.F. Hyperleptinemia precipitates diet-induced obesity in transgenic mice overexpressing leptin. Endocrinology 2003, 144:2865-2869.
36. Storlien L.H., Pan D.A., Kriketos A.D., Baur L.A. High-fat diet-induced insulin resistance. Lessons and implications from animal studies. Ann N Y Acad Sci 1993, 683:82-90.
37. Chien C.S., Cheng S.C., Wu H.T., Tsao C.W., Cheng J.T. Insulin resistance induced by glucosamine in fructose-fed rats. Horm Metab Res 2009, 41:542-547.
38. Muniyappa R., Karne R.J., Hall G., Crandon S.K., Bronstein J.A., Ver M.R., et al. Oral glucosamine for 6 weeks at standard doses does not cause or worsen insulin resistance or endothelial dysfunction in lean or obese subjects. Diabetes 2006, 55:3142-3150.
39. Pouwels M.J., Jacobs J.R., Span P.N., Luttreman J.A., Smits P., Tack C.J. Short-term glucosamine infusion does not affect insulin sensitivity in humans. J Clin Endocrinol Metab 2001, 86:2099-2103.
40. Kaneto H., Xu G., Song K.H., Suzuma K., Bonner-Weir S., Sharma A., et al. Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress. J Biol Chem 2001, 276:31099-31104.
41. Yoshikawa H., Tajiri Y., Sako Y., Hashimato T., Umeda F., Nawata H. Glucosamine-induced beta-cell dysfunction: a possible involvement of glucokinase or glucose-transporter type 2. Pancreas 2002, 24:228-234.
42. Balkan B., Dunning B.E. Glucosamine inhibits glucokinase in vitro and produces a glucose-specific impairment of in vivo insulin secretion in rats. Diabetes 1994, 43:1173-1179.
43. Giaccari A., Morviducci L., Zorretta D., Sbraccia P., Leonetti F., Caiola S., et al. In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycemia. Diabetologia 1995, 38:518-524.
44. Shankar R.R., Zhu J.S., Baron A.D. Glucosamine infusion in rats mimics the beta-cell dysfunction of non-insulin dependent diabetes mellitus. Metabolism 1998, 47:573-577.
45. Monauni T., Zenti M.G., Cretti A., Daniels M.C., Targher G., Caruso B., et al. Effects of glucosamine infusion on insulin secretion and insulin action in humans. Diabetes 2000, 49:926-935.
46. Han L.K., Kimura Y., Okuda H. Reduction in fat storage during chitin-chitosan treatment in mice fed a high-fat diet. Int J Obes Relat Metab Disord 1999, 23:174-179.
47. Wang X., Yang W.Y., Xiao J.Z., Zhao W.H., Wang N., Liu X.L., et al. The effect of high fat feeding and rosiglitazone intervention on pancreatic alpha cell in rats {article in Chinese}. Zhonghua Nei Ke ZA Zhi 2005, 44:601-605.
48. Cano P., Jiménez-Ortega V., Larrad A., Reyes Toso C.F., Cardinali D.P., Esquifino A.L. Effect of a high-fat diet on 24-h pattern of circulating levels of prolactin, luteinizing hormone, testosterone, corticosterone, thyroid-stimulating hormone and glucose, and pineal melatonin content, in rats. Endocrine 2008, 33:118-125.
49. Considine R.V., Cooksey R.C., Williams L.B., Fawcett R.L., Zhang P., Ambrosius W.T., et al. Hexosamines regulate leptin production in human subcutaneous adipocytes. J Clin Endocrinol Metab 2000, 85:3551-3556.
50. Frederich R.C., Hamann A., Anderson S., Lollman B., Lowell B.B., Flier J.S. Leptin levels reflect body lipid content in mice: evidence for diet-induced resistance to leptin action. Nat Med 1995, 1:1311-1314.
51. Kong C.S., Kim J.A., Kim S.K. Anti-obesity effect of sulfated glucosamine by AMPK signal pathway in 3T3-L1 adipocytes. Food Chem Toxicol 2009, 47:2401-2406.
52. Marshall S., Nadeau O., Yamasaki K. Dynamic action of glucose and glucosamine on hexosamine biosynthesis in isolated adipocytes. J Biol Chem 2004, 279:35313-35319.
53. Veerababu G., Tang J., Hoffman R.T., Daniels M.C., Hebert L.F., Crook E.D., et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in the liver of transgenic mice results in enhanced glycogen storage, hyperlipidemia, obesity, and impaired glucose tolerance. Diabetes 2000, 49:2070-2078.
54. Tang J., Neidigh J.L., Cooksey R.C., McClain D.A. Transgenic mice with increased hexosamine flux specifically targeted to β-cells exhibit hyperinsulinemia and peripheral insulin resistance. Diabetes 2000, 49:1492-1499.
55. Hazel M., Cooksey R.C., Jones D., Parker G., Neidigh J.L., Whiterbee B., et al. Activation of the hexosamine signaling pathway in adipose tissue results in decreased serum adiponectin and skeletal muscle insulin resistance. Endocrinology 2004, 145:2118-2128.
56. Cooksey R.C., Hebert L.F., Zhu J.H., Wofford P., Garvey W.T., McClain D.A. Mechanism of hexosamine-induced insulin resistance in transgenic mice overexpressing glutamine:fructose-6-phosphate amidotransferase: decreased glucose transporter GLUT4 translocation and reversal by treatment with thiazolidinedione. Endocrinology 1999, 140:1151-1157.
57. Hebert L.F., Daniels M.C., Zhou J., Crook E.D., Turner R.L., Simmons S.T., et al. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 1996, 98:930-936.
58. Miles P.D.G., Higo K., Romeo O.M., Lee M.K., Rafaat K., Olefsky J.M. Troglitazone prevents hyperglycemia-induced but not glucosamine-induced insulin resistance. Diabetes 1998, 47:395-400.
59. Nelson B.A., Robinson K.A., Buse M.G. High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 2000, 49:981-991.
60. Han D.H., Chen M.M., Holloszy J.O. Glucosamine and glucose induce insulin resistance by different mechanisms in rat skeletal muscle. Am J Physiol Endocrinol Metab 2003, 285:E1267-E1272.